메뉴 건너뛰기




Volumn 4, Issue 1, 2008, Pages 19-21

Post-menopausal hormone therapy and cardiovascular events: A new paradigm based on pharmacogenetics?

Author keywords

Coronary heart disease; Estrogen; Glycoprotein; Hormone therapy; Pharmacogenetics; Platelets; Single nucleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; ESTROGEN; GESTAGEN; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN VI;

EID: 38049141573     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/14796678.4.1.19     Document Type: Article
Times cited : (1)

References (8)
  • 1
    • 33847371760 scopus 로고    scopus 로고
    • Effect of genetic variations in platelet glycoproteins Ibα and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy
    • Bray PF, Howard TD, Vittinghoff E, Sane DC, Herrington DM: Effect of genetic variations in platelet glycoproteins Ibα and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy. Blood 109, 1862-1869 (2007).
    • (2007) Blood , vol.109 , pp. 1862-1869
    • Bray, P.F.1    Howard, T.D.2    Vittinghoff, E.3    Sane, D.C.4    Herrington, D.M.5
  • 2
    • 0037153707 scopus 로고    scopus 로고
    • Oestrogen therapy for prevention of reinfarction in postmenopausal women: A randomised placebo controlled trial
    • Cherry N, Gilmour K, Hannaford P et al.: Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet360, 2001-2008 (2002).
    • (2002) Lancet , vol.360 , pp. 2001-2008
    • Cherry, N.1    Gilmour, K.2    Hannaford, P.3
  • 3
    • 0032547326 scopus 로고    scopus 로고
    • Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    • Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280, 605-613 (1998).
    • (1998) JAMA , vol.280 , pp. 605-613
    • Hulley, S.1    Grady, D.2    Bush, T.3
  • 4
    • 0037014584 scopus 로고    scopus 로고
    • Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/ Progestin Replacement Study follow-up (HERS II)
    • Grady D, Herrington D, Bittner V et al.: Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/ Progestin Replacement Study follow-up (HERS II). JAMA 288, 49-57 (2002).
    • (2002) JAMA , vol.288 , pp. 49-57
    • Grady, D.1    Herrington, D.2    Bittner, V.3
  • 5
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Rossouw JE, Anderson GL, Prentice RL et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333 (2002).
    • (2002) JAMA , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3
  • 6
    • 0042093742 scopus 로고    scopus 로고
    • Estrogen plus progestin and the risk of coronary heart disease
    • Manson JE, Hsia J. Johnson KC et al.: Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349, 523-534 (2003).
    • (2003) N. Engl. J. Med , vol.349 , pp. 523-534
    • Manson, J.E.1    Hsia, J.2    Johnson, K.C.3
  • 7
    • 0034746379 scopus 로고    scopus 로고
    • The P1A polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation
    • Boudoulas KD, Cooke GE, Roos CM, Bray PF, Goldschmidt-Clermont PJ: The P1A polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Arch. Pathol. Lab. Med. 125, 112-115 (2001).
    • (2001) Arch. Pathol. Lab. Med , vol.125 , pp. 112-115
    • Boudoulas, K.D.1    Cooke, G.E.2    Roos, C.M.3    Bray, P.F.4    Goldschmidt-Clermont, P.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.